GSK receives China approval for Nucula treatment
China approval for NuculaThird indication achieved in ChinaNucula has generated £1.3 billion of sales year-to-datePharmaceutical firm GSK (GSK) said it has received approval from the China Medical Products Administration for Nucula,...
03 January 2025
